Editas Medicine, Inc. (NASDAQ:EDIT) Sees Significantly Higher Trading Volume – Modern Readers
Key Gazette |
Editas Medicine, Inc. (NASDAQ:EDIT) Sees Significantly Higher Trading Volume
Modern Readers CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … Investors Recap on Editas Medicine, Inc. (EDIT) |
